JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Alkermes PLC

Fechado

SetorSaúde

26.1 -1.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

26.05

Máximo

26.23

Indicadores-chave

By Trading Economics

Rendimento

-124M

22M

Vendas

-123M

307M

P/E

Médio do Setor

12.695

38.156

EPS

0.291

Margem de lucro

7.329

Funcionários

1,800

EBITDA

-168M

14M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+58.82% upside

Dividendos

By Dow Jones

Próximos Ganhos

29 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.4B

4.4B

Abertura anterior

27.87

Fecho anterior

26.1

Sentimento de Notícias

By Acuity

50%

50%

145 / 375 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Alkermes PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de jul. de 2025, 17:53 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750 Million Windfall

25 de jul. de 2025, 15:58 UTC

Ganhos
Grandes Movimentos do Mercado

Aon Shares Rise After 2Q Earnings Beat

25 de jul. de 2025, 15:08 UTC

Grandes Movimentos do Mercado

AST SpaceMobile Shares Slide After Convertible Notes, Stock Offerings

25 de jul. de 2025, 21:40 UTC

Conversa de Mercado

Starbucks' Spending Hikes Are Misdirected -- Market Talk

25 de jul. de 2025, 21:23 UTC

Conversa de Mercado

Honeywell's Growth Seen Holding Up Despite Recent Headwinds -- Market Talk

25 de jul. de 2025, 20:40 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 20:10 UTC

Ganhos

These Stocks Moved the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 19:56 UTC

Ganhos

Correction to Why Bargain Hunters Are Flocking to 'Bin Stores' -- Barrons.com on July 20

25 de jul. de 2025, 19:14 UTC

Conversa de Mercado

Oil Futures Post Back-to-Back Weekly Losses -- Market Talk

25 de jul. de 2025, 19:10 UTC

Conversa de Mercado

U.S. Natural Gas Futures Appear to Stabilize -- Market Talk

25 de jul. de 2025, 19:01 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 18:45 UTC

Conversa de Mercado

Gold Ends Down Week on Lower Note -- Market Talk

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Sale Could Fetch Around $1B, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH in Talks to Sell Marc Jacobs -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Suitors for Marc Jacobs Include Authentic, Bluestar Alliance and WHP Global, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH Exploring Sale of Fashion Brand Marc Jacobs, Sources Say -- WSJ

25 de jul. de 2025, 17:38 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750M Windfall

25 de jul. de 2025, 17:26 UTC

Conversa de Mercado

U.S. Oil Rig Count Extends Decline -- Market Talk

25 de jul. de 2025, 17:13 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 16:46 UTC

Ganhos

Volkswagen Teases Made-in-America Audis, Porsches After $1.5 Billion Tariff Hit -- 2nd Update

25 de jul. de 2025, 16:45 UTC

Ganhos

Apple Earnings Are Next Week. Why This Analyst Says Be Cautious. -- Barrons.com

25 de jul. de 2025, 16:27 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

25 de jul. de 2025, 16:02 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Berkshire Stock Is Losing Its Buffett Premium. Now Is the Time to Buy. -- Barrons.com

25 de jul. de 2025, 15:34 UTC

Ganhos

Intel's Harsh Reality Nullifies Tariff Boost -- WSJ

25 de jul. de 2025, 15:06 UTC

Conversa de Mercado

Base Metal Prices Fall on Stronger U.S. Dollar -- Market Talk

25 de jul. de 2025, 15:05 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Comfort Systems, and More -- Barrons.com

25 de jul. de 2025, 14:45 UTC

Conversa de Mercado

Oil Rangebound Amid U.S.-EU Trade Uncertainty -- Market Talk

25 de jul. de 2025, 14:44 UTC

Conversa de Mercado

Gold Futures Set to End Week Lower on Easing Trade War Concerns -- Market Talk

25 de jul. de 2025, 14:36 UTC

Conversa de Mercado
Ganhos

Phillips 66 CEO Says California Administration Supports of LA Plant Closure -- Market Talk

Comparação entre Pares

Variação de preço

Alkermes PLC Previsão

Preço-alvo

By TipRanks

58.82% parte superior

Previsão para 12 meses

Média 41.5 USD  58.82%

Máximo 54 USD

Mínimo 34 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Alkermes PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

15 ratings

10

Comprar

5

Manter

0

Vender

Pontuação Técnica

By Trading Central

27.95 / 30.91Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

145 / 375 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.